Youcare Pharmaceutical Group (688658.SH): YKYY025 injection is approved for FDA clinical trials.

10/01/2025

Yuekang Pharmaceutical (688658.SH) announced that its wholly-owned subsidiary Hangzhou Tianlong Pharmaceutical Co., Ltd. (referred to as "...

Youcare Pharmaceutical Group (688658.SH) announced that its wholly-owned subsidiary Hangzhou Tianlong Pharmaceutical Co., Ltd. (referred to as "Hangzhou Tianlong") recently received a letter from the U.S. Food and Drug Administration (FDA) approving clinical trials of YKYY025 injection to prevent lower respiratory tract diseases caused by respiratory syncytial virus (RSV).

C HEALTH GP(08225) officially launches multiple AI-RWS research projects, leading the new track of "AI+ clinical research".

The comprehensive net asset value per share of WALNUT CAP (00905) at the end of August is approximately HK$0.289.

SUMMI(00756): The hearing has been postponed to October 6th.

C HEALTH GP(08225) officially launches multiple AI-RWS research projects, leading the new track of "AI+ clinical research".

The comprehensive net asset value per share of WALNUT CAP (00905) at the end of August is approximately HK$0.289.

SUMMI(00756): The hearing has been postponed to October 6th.